BMI percentile trajectories and liver enzyme changes in children with metabolic dysfunction–associated steatotic liver disease: A longitudinal cohort study

OBJECTIVES: The incidence of pediatric obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) are rapidly rising. However, the impact of dynamic body mass index (BMI) changes on liver chemistries remains understudied. We investigated the association between longitudinal changes in BMI percentile and changes in liver chemistries among children with MASLD. METHODS: In this multicenter study, 1169 children with biopsy-confirmed MASLD enrolled in the Nonalcoholic Steatohepatitis Clinical Research Network were followed for a mean of 4.0 years. BMI percentiles were calculated using the lambda-mu-sigma method with an extended metric to capture nuances at extreme values. Generalized linear mixed-effects models with random effects for patients and clinics were applied, and inverse probability treatment weighting adjusted for demographics and baseline histologic features. Sensitivity analyses stratified by sex and ethnicity assessed robustness. RESULTS: Participants (mean age 13 years; 72% Hispanic) with higher BMI percentiles exhibited elevated blood pressures, increased insulin levels, and a lower frequency of the patatin-like phospholipase domain-containing protein 3 (PNPLA3) GG variant. Each 5-unit increase in BMI percentile was independently associated with a 23% increase in alanine aminotransferase (1.23; 95% confidence interval [CI], 1.17-1.30), a 13% increase in aspartate aminotransferase (1.13; 95% CI, 1.09-1.17), and a 12% increase in γ‑glutamyl transferase (1.12; 95% CI, 1.08-1.16). CONCLUSIONS: Longitudinal increases in BMI percentile are independently associated with worse liver chemistry in pediatric MASLD. Routine monitoring of BMI trajectories, alongside early weight management strategies, may be critical to mitigating disease progression. Trial Registration ClinicalTrials.gov: NCT01061684, NCT04454463.

Authors

Institutions

Publication Details

Journal
Journal of Pediatric Gastroenterology and Nutrition
Published
2026-11-18
DOI
https://doi.org/10.1002/jpn3.70672
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

BMI percentile trajectories and liver enzyme changes in children with metabolic dysfunction–associated steatotic liver disease: A longitudinal cohort study

Patricia H. Belt, Marialena Mouzaki, Lauren F. Chun, Stavra A. Xanthakos et al.
Journal of Pediatric Gastroenterology and Nutrition
Liver Disease Diagnosis and Treatment
article

BMI percentile trajectories and liver enzyme changes in children with metabolic dysfunction–associated steatotic liver disease: A longitudinal cohort study

Patricia H. Belt, Marialena Mouzaki, Lauren F. Chun, Stavra A. Xanthakos, Kimberly P. Newton, Cynthia A. Behling, Laura Wilson, Gretchen Bandoli, Rany M. Salem, Jeffrey B. Schwimmer, Nhat Quang N. Thai, John E. Alcaraz, Jamie Klapp, Noe Crespo
article en

Abstract

OBJECTIVES: The incidence of pediatric obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) are rapidly rising. However, the impact of dynamic body mass index (BMI) changes on liver chemistries remains understudied. We investigated the association between longitudinal changes in BMI percentile and changes in liver chemistries among children with MASLD. METHODS: In this multicenter study, 1169 children with biopsy-confirmed MASLD enrolled in the Nonalcoholic Steatohepatitis Clinical Research Network were followed for a mean of 4.0 years. BMI percentiles were calculated using the lambda-mu-sigma method with an extended metric to capture nuances at extreme values. Generalized linear mixed-effects models with random effects for patients and clinics were applied, and inverse probability treatment weighting adjusted for demographics and baseline histologic features. Sensitivity analyses stratified by sex and ethnicity assessed robustness. RESULTS: Participants (mean age 13 years; 72% Hispanic) with higher BMI percentiles exhibited elevated blood pressures, increased insulin levels, and a lower frequency of the patatin-like phospholipase domain-containing protein 3 (PNPLA3) GG variant. Each 5-unit increase in BMI percentile was independently associated with a 23% increase in alanine aminotransferase (1.23; 95% confidence interval [CI], 1.17-1.30), a 13% increase in aspartate aminotransferase (1.13; 95% CI, 1.09-1.17), and a 12% increase in γ‑glutamyl transferase (1.12; 95% CI, 1.08-1.16). CONCLUSIONS: Longitudinal increases in BMI percentile are independently associated with worse liver chemistry in pediatric MASLD. Routine monitoring of BMI trajectories, alongside early weight management strategies, may be critical to mitigating disease progression. Trial Registration ClinicalTrials.gov: NCT01061684, NCT04454463.

Journal of Pediatric Gastroenterology and Nutrition
Cincinnati Children's Hospital Medical Center (US), Johns Hopkins University (US), San Diego State University (US), University of California San Diego (US), Rady Children's Hospital-San Diego (US), Human Longevity (United States) (US), University of Cincinnati (US)
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon